MPA given orally during the first trimester for threatened miscarriage carries no specific risk for foetal abnormalities albeit the rate is higher than non-threatened pregnancies

Autor: Yovich, John Lui *, Mariappen, Uma, Hinchliffe, Peter Michael, Dhaliwal, Satvinder Singh, Keane, Kevin Noel
Zdroj: In Reproductive Biology September 2020 20(3):424-432
Databáze: ScienceDirect